360 related articles for article (PubMed ID: 27516211)
1. Fibrosis of extracellular matrix is related to the duration of the disease but is unrelated to the dynamics of collagen metabolism in dilated cardiomyopathy.
Rubiś P; Wiśniowska-Śmialek S; Wypasek E; Biernacka-Fijalkowska B; Rudnicka-Sosin L; Dziewiecka E; Faltyn P; Khachatryan L; Karabinowska A; Kozanecki A; Tomkiewicz-Pająk L; Podolec P
Inflamm Res; 2016 Dec; 65(12):941-949. PubMed ID: 27516211
[TBL] [Abstract][Full Text] [Related]
2. 12-month patterns of serum markers of collagen synthesis, transforming growth factor and connective tissue growth factor are similar in new-onset and chronic dilated cardiomyopathy in patients both with and without cardiac fibrosis.
Rubiś P; Wiśniowska-Smiałek S; Wypasek E; Rudnicka-Sosin L; Hlawaty M; Leśniak-Sobelga A; Kostkiewicz M; Podolec P
Cytokine; 2017 Aug; 96():217-227. PubMed ID: 28460256
[TBL] [Abstract][Full Text] [Related]
3. Left ventricular reverse remodeling is not related to biopsy-detected extracellular matrix fibrosis and serum markers of fibrosis in dilated cardiomyopathy, regardless of the definition used for LVRR.
Rubiś P; Wiśniowska-Śmiałek S; Biernacka-Fijałkowska B; Rudnicka-Sosin L; Wypasek E; Kozanecki A; Dziewięcka E; Faltyn P; Karabinowska A; Khachatryan L; Hlawaty M; Leśniak-Sobelga A; Kostkiewicz M; Płazak W; Podolec P
Heart Vessels; 2017 Jun; 32(6):714-725. PubMed ID: 28004175
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of fibrosis-related markers in dilated cardiomyopathy: A link between osteopontin and cardiovascular events.
Rubiś P; Wiśniowska-Śmiałek S; Dziewięcka E; Rudnicka-Sosin L; Kozanecki A; Podolec P
Adv Med Sci; 2018 Mar; 63(1):160-166. PubMed ID: 29120858
[TBL] [Abstract][Full Text] [Related]
5. Relationships between circulating galectin-3, extracellular matrix fibrosis and outcomes in dilated cardiomyopathy.
Rubiś P; Holcman K; Dziewięcka E; Wiśniowska-Śmiałek S; Karabinowska A; Szymonowicz M; Khachatryan L; Wypasek E; Garlitski A; Gackowski A; Podolec P
Adv Clin Exp Med; 2021 Mar; 30(3):245-253. PubMed ID: 33754503
[TBL] [Abstract][Full Text] [Related]
6. Elevated serum markers of collagen degradation in patients with mild to moderate dilated cardiomyopathy.
Schwartzkopff B; Fassbach M; Pelzer B; Brehm M; Strauer BE
Eur J Heart Fail; 2002 Aug; 4(4):439-4. PubMed ID: 12167381
[TBL] [Abstract][Full Text] [Related]
7. Right ventricular morphology and function is not related with microRNAs and fibrosis markers in dilated cardiomyopathy.
Rubiś P; Totoń-Żurańska J; Wiśniowska-Śmiałek S; Kołton-Wróż M; Wołkow P; Wypasek E; Rudnicka-Sosin L; Pawlak A; Kozanecki K; Tomkiewicz-Pająk L; Podolec P
Cardiol J; 2018; 25(6):722-731. PubMed ID: 28840590
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of selected serum markers of fibrosis in patients with dilated cardiomyopathy and different grades of diastolic dysfunction of the left ventricle.
Wiśniowska-Śmiałek S; Dziewięcka E; Holcman K; Wypasek E; Khachatryan L; Karabinowska A; Szymonowicz M; Leśniak-Sobelga A; Hlawaty M; Kostkiewicz M; Podolec P; Rubiś P
Cardiol J; 2020; 27(6):726-734. PubMed ID: 30484268
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1, B⁺ tenascin-C and ED-A⁺ fibronectin in dilated cardiomyopathy: potential impact on disease progression and patients' prognosis.
Franz M; Berndt A; Neri D; Galler K; Grün K; Porrmann C; Reinbothe F; Mall G; Schlattmann P; Renner A; Figulla HR; Jung C; Küthe F
Int J Cardiol; 2013 Oct; 168(6):5344-51. PubMed ID: 23998545
[TBL] [Abstract][Full Text] [Related]
10. Serum markers of deranged myocardial collagen turnover: their relation to malignant ventricular arrhythmias in cardioverter-defibrillator recipients with heart failure.
Flevari P; Theodorakis G; Leftheriotis D; Kroupis C; Kolokathis F; Dima K; Anastasiou-Nana M; Kremastinos D
Am Heart J; 2012 Oct; 164(4):530-7. PubMed ID: 23067911
[TBL] [Abstract][Full Text] [Related]
11. Collagen I and III, MMP-1 and TIMP-1 immunoexpression in dilated cardiomyopathy.
Mihailovici AR; Deliu RC; Mărgăritescu C; Simionescu CE; Donoiu I; Istrătoaie O; Tudoraşcu DR; Târtea EA; Gheonea DI
Rom J Morphol Embryol; 2017; 58(3):777-781. PubMed ID: 29250654
[TBL] [Abstract][Full Text] [Related]
12. Aortic stiffness correlates with an increased extracellular matrix turnover in patients with dilated cardiomyopathy.
Bonapace S; Rossi A; Cicoira M; Golia G; Zanolla L; Franceschini L; Conte L; Marino P; Zardini P; Vassanelli C
Am Heart J; 2006 Jul; 152(1):93.e1-6. PubMed ID: 16824836
[TBL] [Abstract][Full Text] [Related]
13. Circulating matrix metalloproteinases 1, 2, 9 and their inhibitors TIMP-1 and TIMP-2 as serum markers of liver fibrosis in patients with chronic hepatitis C: comparison with PIIINP and hyaluronic acid.
Leroy V; Monier F; Bottari S; Trocme C; Sturm N; Hilleret MN; Morel F; Zarski JP
Am J Gastroenterol; 2004 Feb; 99(2):271-9. PubMed ID: 15046217
[TBL] [Abstract][Full Text] [Related]
14. Increased myocardial collagen turnover in patients with progressive cardiac conduction disease.
Bozkaya YT; Aydin HH; Celik HA; Kayikcioglu M; Payzin S; Kultursay H; Aydin M; Yesil M; Can LH; Hasdemir C
Pacing Clin Electrophysiol; 2008 Oct; 31(10):1284-90. PubMed ID: 18811809
[TBL] [Abstract][Full Text] [Related]
15. Fibrosis in endstage human heart failure: severe changes in collagen metabolism and MMP/TIMP profiles.
Polyakova V; Loeffler I; Hein S; Miyagawa S; Piotrowska I; Dammer S; Risteli J; Schaper J; Kostin S
Int J Cardiol; 2011 Aug; 151(1):18-33. PubMed ID: 20546954
[TBL] [Abstract][Full Text] [Related]
16. Myocardial collagen turnover in hypertrophic cardiomyopathy.
Lombardi R; Betocchi S; Losi MA; Tocchetti CG; Aversa M; Miranda M; D'Alessandro G; Cacace A; Ciampi Q; Chiariello M
Circulation; 2003 Sep; 108(12):1455-60. PubMed ID: 12952838
[TBL] [Abstract][Full Text] [Related]
17. Interstitial fibrosis in the heart: differences in extracellular matrix proteins and matrix metalloproteinases in end-stage dilated, ischaemic and valvular cardiomyopathy.
Herpel E; Pritsch M; Koch A; Dengler TJ; Schirmacher P; Schnabel PA
Histopathology; 2006 May; 48(6):736-47. PubMed ID: 16681691
[TBL] [Abstract][Full Text] [Related]
18. Procollagen type I carboxy-terminal propeptide (PICP) and MMP-2 are potential biomarkers of myocardial fibrosis in patients with hypertrophic cardiomyopathy.
Yang C; Qiao S; Song Y; Liu Y; Tang Y; Deng L; Yuan J; Hu F; Yang W
Cardiovasc Pathol; 2019; 43():107150. PubMed ID: 31639652
[TBL] [Abstract][Full Text] [Related]
19. Assessment of myocardial fibrosis by late gadolinium enhancement imaging and biomarkers of collagen metabolism in chronic rheumatic mitral regurgitation.
Meel R; Nethononda R; Libhaber E; Dix-Peek T; Peters F; Essop M
Cardiovasc J Afr; 2018 May/Jun 23; 29(3):150-154. PubMed ID: 29443354
[TBL] [Abstract][Full Text] [Related]
20. Cytokines, interstitial collagen and ventricular remodelling in dilated cardiomyopathy.
Timonen P; Magga J; Risteli J; Punnonen K; Vanninen E; Turpeinen A; Tuomainen P; Kuusisto J; Vuolteenaho O; Peuhkurinen K
Int J Cardiol; 2008 Mar; 124(3):293-300. PubMed ID: 17442428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
